Location: Danville
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Danville
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
BioHealx® Anal Fistula Device Post Market Surveillance Study Phase N/A · Geisinger · Signum Surgical USA Inc. · NCT07021742 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi Phase 2 · Carle at The Riverfront · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G Phase 1/Phase 2 · Geisinger Medical Center · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed Phase 3 · Geisinger Medical Center · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C Phase 3 · Carle at The Riverfront · NRG Oncology · NCT05624996 M-Vizion™ Macroscopic Radiographic Study Phase N/A · Geisinger Medical Center · Medacta USA · NCT05721859 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au Phase 3 · Local Institution - 0143 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C Phase 3 · Carle at The Riverfront · Alliance for Clinical Trials in Oncology · NCT07321652 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma Phase 2/Phase 3 · Geisinger Medical Center · National Cancer Institute (NCI) · NCT05691478 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer NA · Carle at The Riverfront · Alliance for Clinical Trials in Oncology · NCT07091617 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients Phase N/A · Geisinger Medical Center · PrECOG, LLC. · NCT06538038 Non-Invasive Preeclampsia Screening and Biobank Phase N/A · Geisinger Medical Center · Sequenom, Inc. · NCT06643741 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT Phase 2 · Geisinger Medical Center · Children's Oncology Group · NCT04322318 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer Phase 3 · Carle at The Riverfront · NRG Oncology · NCT05946213 Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis Phase N/A · Research Site · AstraZeneca · NCT06465810 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient Phase 2 · Carle at The Riverfront · NRG Oncology · NCT06532279 Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations Phase N/A · Geisinger Medical Center · National Institute of Mental Health (NIMH) · NCT04639830 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Phase 2/Phase 3 · Carle at The Riverfront · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc Phase 3 · Carle at The Riverfront · Alliance for Clinical Trials in Oncology · NCT06632327 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati Phase 3 · Carle at The Riverfront · Alliance for Clinical Trials in Oncology · NCT06931340 RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT Phase N/A · Geisinger Health System · The Radiosurgery Society · NCT01885299 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol Phase 3 · Carle at The Riverfront · Alliance for Clinical Trials in Oncology · NCT06876714 Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or Phase 3 · Geisinger Medical Center · Canadian Cancer Trials Group · NCT03550391 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL Phase 3 · Carle at The Riverfront · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S Phase 3 · Geisinger Medical Center · Canadian Cancer Trials Group · NCT06592924 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A Phase 3 · Geisinger Medical Center · Children's Oncology Group · NCT04293562 E-Mindfulness Approaches for Living After Breast Cancer Phase 3 · Carle at The Riverfront · NRG Oncology · NCT06748222 Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggress Phase 2 · Carle at The Riverfront · National Cancer Institute (NCI) · NCT06649812 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Phase 3 · Geisinger Medical Center · NRG Oncology · NCT03180268 A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participant Phase 2 · Sovah Clinical Research-River District · Eli Lilly and Company · NCT07589608
Look up another city
Look up another condition